AbbVie Shares (Diluted) increased by 0.1% to 1.8B in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 1.8B to 1.8B. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to basic shares indicates a higher reliance on equity-based compensation or convertible debt financing.
Weighted-average shares outstanding (diluted) includes the total number of basic common shares plus all additional share...
Commonly compared against basic shares to determine the 'dilution overhang' present in a company's capital structure.
is_weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B |
| QoQ Change | — | +0.1% | +0.1% | -0.1% | +0.0% | +0.0% | -0.3% | +0.0% | +0.1% | -0.1% | +0.1% | +0.0% | -0.1% | +0.1% |
| YoY Change | — | — | — | +0.0% | -0.1% | -0.1% | -0.3% | -0.3% | -0.2% | +0.0% | +0.1% | -0.1% | +0.0% | +0.0% |